Exhibit 1
Joint Filing Agreement
This will confirm the agreement as of February 8, 2005 by and among all
the undersigned that the Statement on Schedule 13G filed on or about this date
and any further amendments thereto with respect to beneficial ownership by the
undersigned of the shares of the common stock, $.001 par value per share, of
Immunicon Corporation, a Delaware corporation, is being filed on behalf of each
of the undersigned in accordance with Rule 13d-1(k)(1) under the Securities
Exchange Act of 1934.
The undersigned further agree that each party hereto is responsible for
timely filing of such Statement on Schedule 13G and any amendments thereto, and
for the completeness and accuracy of the information concerning such party
contained therein, provided that no party is responsible for the completeness
and accuracy of the information concerning any other party, unless such party
knows or has reason to believe that such information is inaccurate. The
undersigned further agree that this agreement shall be included as an Exhibit to
such joint filing.
This agreement may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and
the same instrument.
MDS Capital Corp.
By: /s/ Xxxxxxx Xxxxxx By: /s/ Graysanne Xxxxxx
---------------------------- -----------------------
Name: Xxxxxxx Xxxxxx Name: Graysanne Xxxxxx
Title: Chief Operating Officer Title: Vice-President -
Legal and Secretary
-2-
MDS Life Sciences Technology Fund
Limited Partnership
By: MDS Life Sciences Technology Fund
(GP) Inc.
By: /s/ Xxxxxxx Xxxxxx By: /s/ Graysanne Xxxxxx
---------------------------- -----------------------
Name: Xxxxxxx Xxxxxx Name: Graysanne Xxxxxx
Title: Vice-President Title: Secretary
MDS Life Sciences Technology Fund USA, L.P.
By: MDS Capital USA (GP) Inc.
By: /s/ Xxxxxxx Xxxxxx By: /s/ Xxxxxxx Xxxxxxx
---------------------------- -----------------------
Name: Xxxxxxx Xxxxxx Name: Xxxxxxx Xxxxxxx
Title: Vice-President Title: President
-3-
MDS Life Sciences Technology Barbados
Investment Trust
By:
By: /s/ Xxxxxxx Xxxxxx
----------------------------
Name: Xxxxxxx Xxxxxx
Title: Trustee
SC Biotechnology Development Fund LP
By: SC (GP) Inc., its General Partner
By: /s/ Xxxx Xxxxxxxx By: /s/ Xxxxxxx Walmsely
---------------------------- -----------------------
Name: Xxxx Xxxxxxxx Name: Xxxxxxx Xxxxxxxx
Title: Directors of Cardinal Title: Director of Cardinal
Investments Limited Investments Limited
(Director of SC (Director of SC
(GP) Inc.) (GP) Inc.)
MDS Life Sciences Technology Fund
(GP) Inc.
By: /s/ Xxxxxxx Xxxxxx By: /s/ Graysanne Xxxxxx
---------------------------- -----------------------
Name: Xxxxxxx Xxxxxx Name: Graysanne Xxxxxx
Title: Vice-President Title: Secretary
-4-
MDS Capital USA (GP) Inc.
By: /s/ Xxxxxxx Xxxxxx By: /s/ Xxxxxxx Xxxxxxx
---------------------------- -----------------------
Name: Xxxxxxx Xxxxxx Name: Xxxxxxx Xxxxxxx
Title: Vice-President Title: President
SC (GP) Inc.
By: /s/ Xxxx Xxxxxxxx By: /s/ Xxxxxxx Walmsely
---------------------------- -----------------------
Name: Xxxx Xxxxxxxx Name: Xxxxxxx Xxxxxxxx
Title: Directors of Cardinal Title: Director of Cardinal
Investments Limited Investments Limited
(Director of SC (Director of SC
(GP) Inc.) (GP) Inc.)
MDS Capital Management Corp.
By: /s/ Xxxxxxx Xxxxxx By: /s/ Graysanne Xxxxxx
---------------------------- -----------------------
Name: Xxxxxxx Xxxxxx Name: Graysanne Xxxxxx
Title: Chief Operating Officer Title: Vice-President -
Legal and Secretary
